IBDEI0WK ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15827,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,15828,0)
 ;;=528.2^^81^948^43
 ;;^UTILITY(U,$J,358.3,15828,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15828,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,15828,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,15828,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,15829,0)
 ;;=692.72^^81^948^44
 ;;^UTILITY(U,$J,358.3,15829,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15829,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,15829,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,15829,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,15830,0)
 ;;=692.6^^81^948^46
 ;;^UTILITY(U,$J,358.3,15830,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15830,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,15830,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,15830,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,15831,0)
 ;;=698.0^^81^948^62
 ;;^UTILITY(U,$J,358.3,15831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15831,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,15831,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,15831,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,15832,0)
 ;;=698.9^^81^948^61
 ;;^UTILITY(U,$J,358.3,15832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15832,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,15832,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,15832,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,15833,0)
 ;;=696.1^^81^948^63
 ;;^UTILITY(U,$J,358.3,15833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15833,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,15833,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,15833,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,15834,0)
 ;;=287.0^^81^948^64
 ;;^UTILITY(U,$J,358.3,15834,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15834,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,15834,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,15834,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,15835,0)
 ;;=782.1^^81^948^65
 ;;^UTILITY(U,$J,358.3,15835,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15835,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,15835,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,15835,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,15836,0)
 ;;=706.2^^81^948^69
 ;;^UTILITY(U,$J,358.3,15836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15836,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,15836,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,15836,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,15837,0)
 ;;=690.10^^81^948^72
 ;;^UTILITY(U,$J,358.3,15837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15837,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,15837,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,15837,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,15838,0)
 ;;=702.11^^81^948^70
 ;;^UTILITY(U,$J,358.3,15838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15838,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,15838,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,15838,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,15839,0)
 ;;=702.19^^81^948^71
 ;;^UTILITY(U,$J,358.3,15839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15839,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,15839,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,15839,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,15840,0)
 ;;=686.9^^81^948^73
 ;;^UTILITY(U,$J,358.3,15840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15840,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,15840,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,15840,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,15841,0)
 ;;=708.9^^81^948^86
 ;;^UTILITY(U,$J,358.3,15841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15841,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,15841,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;
 ;;$END ROU IBDEI0WK
